Loading...
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EBS’s FA Score shows that 1 FA rating(s) are green whileOPTN’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EBS’s TA Score shows that 6 TA indicator(s) are bullish while OPTN’s TA Score has 5 bullish TA indicator(s).
EBS (@Pharmaceuticals: Other) experienced а +110.58% price change this week, while OPTN (@Pharmaceuticals: Other) price change was +32.68% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.63%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +19052.82%.
EBS is expected to report earnings on Jul 25, 2024.
OPTN is expected to report earnings on Aug 08, 2024.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
EBS | OPTN | EBS / OPTN | |
Capitalization | 120M | 164M | 73% |
EBITDA | -518.2M | -15.55M | 3,332% |
Gain YTD | 65.833 | -11.628 | -566% |
P/E Ratio | 17.73 | N/A | - |
Revenue | 1.02B | 71M | 1,441% |
Total Cash | 112M | 73.7M | 152% |
Total Debt | 860M | 132M | 652% |
EBS | OPTN | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 93 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 28 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 35 | 82 | |
P/E GROWTH RATING 1..100 | 15 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 19 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OPTN's Valuation (28) in the Medical Or Nursing Services industry is somewhat better than the same rating for EBS (76) in the Biotechnology industry. This means that OPTN’s stock grew somewhat faster than EBS’s over the last 12 months.
OPTN's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as EBS (100) in the Biotechnology industry. This means that OPTN’s stock grew similarly to EBS’s over the last 12 months.
EBS's SMR Rating (98) in the Biotechnology industry is in the same range as OPTN (100) in the Medical Or Nursing Services industry. This means that EBS’s stock grew similarly to OPTN’s over the last 12 months.
EBS's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for OPTN (82) in the Medical Or Nursing Services industry. This means that EBS’s stock grew somewhat faster than OPTN’s over the last 12 months.
EBS's P/E Growth Rating (15) in the Biotechnology industry is significantly better than the same rating for OPTN (100) in the Medical Or Nursing Services industry. This means that EBS’s stock grew significantly faster than OPTN’s over the last 12 months.
EBS | OPTN | |
---|---|---|
RSI ODDS (%) | 1 day ago88% | 1 day ago90% |
Stochastic ODDS (%) | 1 day ago77% | 1 day ago89% |
Momentum ODDS (%) | 1 day ago70% | 1 day ago83% |
MACD ODDS (%) | 1 day ago70% | 1 day ago76% |
TrendWeek ODDS (%) | 1 day ago76% | 1 day ago80% |
TrendMonth ODDS (%) | 1 day ago74% | 1 day ago87% |
Advances ODDS (%) | 1 day ago76% | 1 day ago79% |
Declines ODDS (%) | 8 days ago86% | 8 days ago88% |
BollingerBands ODDS (%) | 1 day ago77% | 1 day ago90% |
Aroon ODDS (%) | 1 day ago85% | 1 day ago89% |
A.I.dvisor tells us that OPTN and SUPN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTN and SUPN's prices will move in lockstep.
Ticker / NAME | Correlation To OPTN | 1D Price Change % | ||
---|---|---|---|---|
OPTN | 100% | +12.87% | ||
SUPN - OPTN | 25% Poorly correlated | -1.33% | ||
EBS - OPTN | 23% Poorly correlated | +2.31% | ||
NBIX - OPTN | 22% Poorly correlated | +0.71% | ||
IRWD - OPTN | 21% Poorly correlated | -0.12% | ||
AQST - OPTN | 21% Poorly correlated | -0.57% | ||
More |